Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced it has sold a follow-on order for its Quantum Sniffer(TM) H150 handheld explosives trace detector to First Class Zollservice und Transportvermittlungs GmbH, a current customer in Germany. The sale was made through Implant Sciences' Hamburg-based distributor, D-TeC System Consulting GmbH, a products and consulting business that supports a wide range of security markets including aviation and logistics.
First Class Zollservice has provided professional cargo management and transport services to its client base since 1992. The company has recently expanded its air cargo security capabilities with a mobile screening service that provides explosives trace detection on a fee-per-piece basis for air freight forwarders. This service utilizes a Quantum Sniffer installed in a vehicle that is driven to freight forwarding facilities to perform the cargo screening.
Holger Hille, General Manager of First Class Zollservice, added, "We implemented the first QS-H150 in our newly launched mobile screening service late last year. Implant Sciences' portable trace detector has performed extremely well and we are seeing growing demand for our mobile service, leading to our second QS-H150 order. In Germany we have strict regulations regarding the transportation of equipment that uses radioactive materials. With its advanced design, the QS-H150 has opened a new market for us."
"First Class Zollservice has been very innovative in identifying a new niche market which caters to smaller shippers for whom purchasing screening equipment is not cost effective. In providing screening as a service, this company is offering better economics to a new customer base," stated Implant Sciences' Vice President of Global Sales and Marketing, Dr. Darryl Jones. "We believe that the non-radioactive design of our Quantum Sniffer trace detectors offers a number of opportunities in which we can gain further traction globally."
Source: Implant Sciences Corp.
Date: Jun 27, 2012